Pennsylvania Oncology/Hemotology Dept.ofPenn. Onc./Hem. — Philadelphia, Pennsylvania

Pennsylvania Oncology/Hemotology Dept.ofPenn. Onc./Hem. is a clinical research site located in Philadelphia, Pennsylvania, United States 19106.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Pennsylvania Oncology/Hemotology Dept.ofPenn. Onc./Hem. has participated in 1 clinical trials.

Therapeutic areas: Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Pennsylvania Oncology/Hemotology Dept.ofPenn. Onc./Hem.?

Pennsylvania Oncology/Hemotology Dept.ofPenn. Onc./Hem. has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Pennsylvania Oncology/Hemotology Dept.ofPenn. Onc./Hem. conducted?

Pennsylvania Oncology/Hemotology Dept.ofPenn. Onc./Hem. has 1 clinical trials on record. Their work covers Acute Lymphoblastic Leukemia (ALL), Diffuse Large B-cell Lymphoma (DLBCL).

Is Pennsylvania Oncology/Hemotology Dept.ofPenn. Onc./Hem. accredited by Crixeo Health?

Pennsylvania Oncology/Hemotology Dept.ofPenn. Onc./Hem. has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Pennsylvania Oncology/Hemotology Dept.ofPenn. Onc./Hem.?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.